{
  "data": [
    {
      "cis": "61266250",
      "denomination": "A 313 200 000 UI POUR CENT, pommade",
      "forme_pharma": "pommade",
      "voies_admin": "cutanée",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "12/03/1998",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "PHARMA DEVELOPPEMENT",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "62869109",
      "denomination": "A 313 50 000 U.I., capsule molle",
      "forme_pharma": "capsule molle",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "07/07/1997",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "PHARMA DEVELOPPEMENT",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "69103878",
      "denomination": "A.D.N. BOIRON, degré de dilution compris entre 4CH et 30CH ou entre 8DH et 60DH",
      "forme_pharma": "comprimé et solution(s) et granules et poudre et pommade",
      "voies_admin": "cutanée;orale;sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Enreg homéo (Proc. Nat.)",
      "commercialisation": "Commercialisée",
      "date_amm": "14/10/2021",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BOIRON",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "61876780",
      "denomination": "ABACAVIR ARROW 300 mg, comprimé pelliculé sécable",
      "forme_pharma": "comprimé pelliculé sécable",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "22/10/2019",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "ARROW GENERIQUES",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "63797011",
      "denomination": "ABACAVIR SANDOZ 300 mg, comprimé pelliculé sécable",
      "forme_pharma": "comprimé pelliculé sécable",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "30/12/2016",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "SANDOZ",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "62401060",
      "denomination": "ABACAVIR VIATRIS 300 mg, comprimé pelliculé sécable",
      "forme_pharma": "comprimé pelliculé sécable",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "21/02/2018",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "VIATRIS SANTE",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "68257528",
      "denomination": "ABACAVIR/LAMIVUDINE ACCORD 600 mg/300 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Non commercialisée",
      "date_amm": "16/03/2017",
      "statut_bdm": "Warning disponibilité",
      "num_autorisation_euro": "",
      "titulaire": "ACCORD HEALTHCARE FRANCE",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "62828870",
      "denomination": "ABACAVIR/LAMIVUDINE ARROW 600 mg/300 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "15/12/2017",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "ARROW GENERIQUES",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "63431640",
      "denomination": "ABACAVIR/LAMIVUDINE BIOGARAN 600 mg/300 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "14/02/2017",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BIOGARAN",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "65196479",
      "denomination": "ABACAVIR/LAMIVUDINE EG 600 mg/300 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "13/01/2017",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "EG LABO - LABORATOIRES EUROGENERICS",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "62170486",
      "denomination": "ABACAVIR/LAMIVUDINE MYLAN 600 mg/300 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Non commercialisée",
      "date_amm": "03/03/2017",
      "statut_bdm": "Warning disponibilité",
      "num_autorisation_euro": "",
      "titulaire": "MYLAN SAS",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "67720261",
      "denomination": "ABACAVIR/LAMIVUDINE SANDOZ 600 mg/300 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "03/03/2017",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "SANDOZ",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "65857902",
      "denomination": "ABACAVIR/LAMIVUDINE TEVA 600 mg/300 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "03/05/2017",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "TEVA SANTE",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "67567004",
      "denomination": "ABACAVIR/LAMIVUDINE VIATRIS 600 mg/300 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "08/01/2018",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "VIATRIS SANTE",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "62202005",
      "denomination": "ABACAVIR/LAMIVUDINE ZENTIVA 600 mg/300 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Non commercialisée",
      "date_amm": "30/05/2018",
      "statut_bdm": "Warning disponibilité",
      "num_autorisation_euro": "",
      "titulaire": "ZENTIVA FRANCE",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "63152345",
      "denomination": "ABACAVIR/LAMIVUDINE/ZIDOVUDINE VIATRIS 300 mg/150 mg/300 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "21/12/2017",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "VIATRIS SANTE",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "66513085",
      "denomination": "ABASAGLAR 100 unités/ml, solution injectable en cartouche",
      "forme_pharma": "solution injectable",
      "voies_admin": "sous-cutanée",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "09/09/2014",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/14/944",
      "titulaire": "ELI LILLY NEDERLAND BV (PAY-BAS)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "64332894",
      "denomination": "ABASAGLAR 100 unités/ml, solution injectable en stylo prérempli",
      "forme_pharma": "solution injectable",
      "voies_admin": "sous-cutanée",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "09/09/2014",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/14/944",
      "titulaire": "ELI LILLY NEDERLAND BV (PAY-BAS)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "65329132",
      "denomination": "ABECMA 260 - 500 x 1 000 000 cellules, dispersion pour perfusion",
      "forme_pharma": "dispersion pour perfusion",
      "voies_admin": "intraveineuse",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "18/08/2021",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/21/1539",
      "titulaire": "BRISTOL-MYERS SQUIBB PHARMA (IRLANDE)",
      "surveillance_renforcee": "Oui"
    },
    {
      "cis": "60386663",
      "denomination": "ABELMOSCHUS BOIRON, degré de dilution compris entre 4CH et 30CH ou entre 7DH et 60DH",
      "forme_pharma": "comprimé et solution(s) et granules et poudre et pommade",
      "voies_admin": "cutanée;orale;sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Enreg homéo (Proc. Nat.)",
      "commercialisation": "Commercialisée",
      "date_amm": "01/03/2019",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BOIRON",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "67397826",
      "denomination": "ABEVMY 25 mg/mL, solution à diluer pour perfusion",
      "forme_pharma": "solution à diluer pour perfusion",
      "voies_admin": "intraveineuse",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "21/04/2021",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/20/1515",
      "titulaire": "BIOSIMILAR COLLABORATIONS IRELAND (IRLANDE)",
      "surveillance_renforcee": "Oui"
    },
    {
      "cis": "60538772",
      "denomination": "ABIES CANADENSIS BOIRON, degré de dilution compris entre 2CH et 30CH ou entre 4DH et 60DH",
      "forme_pharma": "comprimé et solution(s) et granules et poudre et pommade",
      "voies_admin": "cutanée;orale;sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Enreg homéo (Proc. Nat.)",
      "commercialisation": "Commercialisée",
      "date_amm": "20/09/2013",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BOIRON",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "65698396",
      "denomination": "ABIES NIGRA BOIRON, degré de dilution compris entre 2CH à 30CH et 4DH à 60DH",
      "forme_pharma": "comprimé et solution(s) et granules et poudre et pommade",
      "voies_admin": "cutanée;orale;sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Enreg homéo (Proc. Nat.)",
      "commercialisation": "Commercialisée",
      "date_amm": "04/08/2016",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BOIRON",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "63075735",
      "denomination": "ABIES PECTINATA BOIRON, degré de dilution compris entre 2CH et 30CH ou entre 4DH et 60DH",
      "forme_pharma": "comprimé et solution(s) et granules et poudre et pommade",
      "voies_admin": "cutanée;orale;sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Enreg homéo (Proc. Nat.)",
      "commercialisation": "Commercialisée",
      "date_amm": "23/07/2010",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BOIRON",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "69985792",
      "denomination": "ABIES PECTINATA LEHNING, degré de dilution compris entre 2CH et 30CH ou entre 4DH et 60DH",
      "forme_pharma": "comprimé et solution(s) et granules et poudre et pommade",
      "voies_admin": "cutanée;orale;sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Enreg homéo (Proc. Nat.)",
      "commercialisation": "Commercialisée",
      "date_amm": "23/07/2010",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "LEHNING",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "64055988",
      "denomination": "ABILIFY 1 mg/mL, solution buvable",
      "forme_pharma": "solution buvable",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "28/10/2005",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/04/276",
      "titulaire": "OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "65198099",
      "denomination": "ABILIFY 10 mg, comprimé",
      "forme_pharma": "comprimé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "04/06/2004",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/04/276",
      "titulaire": "OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "61815891",
      "denomination": "ABILIFY 10 mg, comprimé orodispersible",
      "forme_pharma": "comprimé orodispersible",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "20/06/2005",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/04/276",
      "titulaire": "OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "64224801",
      "denomination": "ABILIFY 15 mg, comprimé",
      "forme_pharma": "comprimé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "04/06/2004",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/04/276",
      "titulaire": "OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "66791654",
      "denomination": "ABILIFY 15 mg, comprimé orodispersible",
      "forme_pharma": "comprimé orodispersible",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "20/06/2005",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/04/276",
      "titulaire": "OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "60599533",
      "denomination": "ABILIFY 5 mg, comprimé",
      "forme_pharma": "comprimé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "04/06/2004",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/04/276",
      "titulaire": "OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "69641873",
      "denomination": "ABILIFY 7,5 mg/ml, solution injectable",
      "forme_pharma": "solution injectable",
      "voies_admin": "intramusculaire",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "04/10/2006",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/04/276",
      "titulaire": "OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "68729480",
      "denomination": "ABILIFY MAINTENA 300 mg, poudre et solvant pour suspension injectable à libération prolongée",
      "forme_pharma": "poudre et  solvant pour suspension injectable à libération prolongée",
      "voies_admin": "intramusculaire",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "15/11/2013",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/13/882",
      "titulaire": "OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "66706942",
      "denomination": "ABILIFY MAINTENA 400 mg, poudre et solvant pour suspension injectable à libération prolongée en seringue préremplie",
      "forme_pharma": "poudre et  solvant pour suspension injectable à libération prolongée",
      "voies_admin": "intramusculaire",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "19/06/2015",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/13/882",
      "titulaire": "OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "63466449",
      "denomination": "ABILIFY MAINTENA 720 mg, suspension injectable à libération prolongée en seringue préremplie",
      "forme_pharma": "suspension injectable à libération prolongée",
      "voies_admin": "intramusculaire",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "25/03/2024",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/13/882",
      "titulaire": "OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "67269958",
      "denomination": "ABILIFY MAINTENA 960 mg, suspension injectable à libération prolongée en seringue préremplie",
      "forme_pharma": "suspension injectable à libération prolongée",
      "voies_admin": "intramusculaire",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "25/03/2024",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/13/882",
      "titulaire": "OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "60621442",
      "denomination": "ABIRATERONE ACCORD 500 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "26/04/2021",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/20/1512",
      "titulaire": "ACCORD HEALTHCARE (ESPAGNE)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "61954108",
      "denomination": "ABIRATERONE ACETATE ZYDUS 500 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "24/08/2021",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "ZYDUS FRANCE",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "65731907",
      "denomination": "ABIRATERONE ARROW 500 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "20/04/2022",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "EUGIA PHARMA (MALTA) (MALTE)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "65412934",
      "denomination": "ABIRATERONE BIOGARAN 500 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure de reconnaissance mutuelle",
      "commercialisation": "Commercialisée",
      "date_amm": "17/11/2021",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BIOGARAN",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "68633208",
      "denomination": "ABIRATERONE CRISTERS 500 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "27/10/2022",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "CRISTERS",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "61760740",
      "denomination": "ABIRATERONE EG 500 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "21/06/2021",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "EG LABO - LABORATOIRES EUROGENERICS",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "66460184",
      "denomination": "ABIRATERONE EVOLUGEN 500 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "24/09/2021",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "EVOLUPHARM",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "68478448",
      "denomination": "ABIRATERONE KRKA 500 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "24/06/2021",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/21/1553",
      "titulaire": "KRKA (SLOVENIE)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "62375509",
      "denomination": "ABIRATERONE MYLAN 500 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "20/08/2021",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/21/1571",
      "titulaire": "MYLAN PHARMACEUTICALS (IRLANDE)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "67430062",
      "denomination": "ABIRATERONE SANDOZ 1000 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "06/07/2021",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "SANDOZ",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "67365440",
      "denomination": "ABIRATERONE SANDOZ 500 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "25/05/2021",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "SANDOZ",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "63001674",
      "denomination": "ABIRATERONE TEVA 500 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "31/05/2022",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "TEVA (PAYS-BAS)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "65665802",
      "denomination": "ABIRATERONE ZENTIVA 500 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "10/11/2021",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "ZENTIVA FRANCE",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "68739019",
      "denomination": "ABRAXANE 5 mg/mL, poudre pour dispersion injectable pour perfusion",
      "forme_pharma": "poudre pour dispersion injectable pour perfusion",
      "voies_admin": "intraveineuse",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "14/01/2008",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/07/428",
      "titulaire": "BRISTOL-MYERS SQUIBB PHARMA (IRLANDE)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "62082709",
      "denomination": "ABROTANUM BOIRON, degré de dilution compris entre 2CH et 30CH ou entre 4DH et 60DH",
      "forme_pharma": "comprimé et solution(s) et granules et poudre et pommade",
      "voies_admin": "cutanée;orale;sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Enreg homéo (Proc. Nat.)",
      "commercialisation": "Commercialisée",
      "date_amm": "19/07/2010",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BOIRON",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "67871676",
      "denomination": "ABROTANUM LEHNING, degré de dilution compris entre 2CH et 30CH ou entre 4DH et 60DH",
      "forme_pharma": "comprimé et solution(s) et granules et poudre et pommade",
      "voies_admin": "cutanée;orale;sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Enreg homéo (Proc. Nat.)",
      "commercialisation": "Commercialisée",
      "date_amm": "19/07/2010",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "LEHNING",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "60990140",
      "denomination": "ABRYSVO, poudre et solvant pour solution injectable. Vaccin du virus respiratoire syncytial (bivalent, recombinant)",
      "forme_pharma": "poudre et  solvant pour solution injectable",
      "voies_admin": "intramusculaire",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "23/08/2023",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/23/1752",
      "titulaire": "PFIZER EUROPE MA EEIG (BELGIQUE)",
      "surveillance_renforcee": "Oui"
    },
    {
      "cis": "64457435",
      "denomination": "ABSINTHIUM BOIRON, degré de dilution compris entre 2CH et 30CH ou entre 4DH et 60DH",
      "forme_pharma": "comprimé et solution(s) et granules et poudre et pommade",
      "voies_admin": "cutanée;orale;sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Enreg homéo (Proc. Nat.)",
      "commercialisation": "Commercialisée",
      "date_amm": "11/02/2011",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BOIRON",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "60612094",
      "denomination": "ABSINTHIUM LEHNING, degré de dilution compris entre 2CH et 30CH ou entre 4DH et 60DH",
      "forme_pharma": "comprimé et solution(s) et granules et poudre et pommade",
      "voies_admin": "cutanée;orale;sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Enreg homéo (Proc. Nat.)",
      "commercialisation": "Commercialisée",
      "date_amm": "27/06/2011",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "LEHNING",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "68336954",
      "denomination": "ABSTRAL 100 microgrammes, comprimé sublingual",
      "forme_pharma": "comprimé",
      "voies_admin": "sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "23/02/2009",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "LABORATOIRES GRUNENTHAL",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "67144513",
      "denomination": "ABSTRAL 200 microgrammes, comprimé sublingual",
      "forme_pharma": "comprimé",
      "voies_admin": "sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "23/02/2009",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "LABORATOIRES GRUNENTHAL",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "61464150",
      "denomination": "ABSTRAL 300 microgrammes, comprimé sublingual",
      "forme_pharma": "comprimé",
      "voies_admin": "sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "23/02/2009",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "LABORATOIRES GRUNENTHAL",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "60282999",
      "denomination": "ABSTRAL 400 microgrammes, comprimé sublingual",
      "forme_pharma": "comprimé",
      "voies_admin": "sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "23/02/2009",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "LABORATOIRES GRUNENTHAL",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "63451714",
      "denomination": "ABSTRAL 600 microgrammes, comprimé sublingual",
      "forme_pharma": "comprimé",
      "voies_admin": "sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "23/02/2009",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "LABORATOIRES GRUNENTHAL",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "61578296",
      "denomination": "ABSTRAL 800 microgrammes, comprimé sublingual",
      "forme_pharma": "comprimé",
      "voies_admin": "sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "23/02/2009",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "LABORATOIRES GRUNENTHAL",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "64728712",
      "denomination": "ABUFENE 400 mg, comprimé",
      "forme_pharma": "comprimé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "23/09/1991",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BOUCHARA-RECORDATI",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "62963238",
      "denomination": "ACALYPHA INDICA BOIRON, degré de dilution compris entre 2CH et 30CH ou entre 4DH et 60DH",
      "forme_pharma": "comprimé et solution(s) et granules et poudre et pommade",
      "voies_admin": "cutanée;orale;sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Enreg homéo (Proc. Nat.)",
      "commercialisation": "Commercialisée",
      "date_amm": "20/09/2013",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BOIRON",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "69724187",
      "denomination": "ACAMPROSATE BIOGARAN 333 mg, comprimé pelliculé gastro-résistant",
      "forme_pharma": "comprimé pelliculé gastro-résistant(e)",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "25/10/2013",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BIOGARAN",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "60929194",
      "denomination": "ACAMPROSATE VIATRIS 333 mg, comprimé enrobé gastro-résistant",
      "forme_pharma": "comprimé enrobé gastro-résistant(e)",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "08/08/2018",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "VIATRIS SANTE",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "61621192",
      "denomination": "ACARBOSE ARROW 100 mg, comprimé sécable",
      "forme_pharma": "comprimé sécable",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "16/07/2020",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "ARROW GENERIQUES",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "69664434",
      "denomination": "ACARBOSE ARROW 50 mg, comprimé",
      "forme_pharma": "comprimé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "16/07/2020",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "ARROW GENERIQUES",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "68371745",
      "denomination": "ACARBOSE ARROW LAB 100 mg, comprimé",
      "forme_pharma": "comprimé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Non commercialisée",
      "date_amm": "31/05/2012",
      "statut_bdm": "Warning disponibilité",
      "num_autorisation_euro": "",
      "titulaire": "GENEVIDA (ALLEMAGNE)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "63958735",
      "denomination": "ACARBOSE ARROW LAB 50 mg, comprimé",
      "forme_pharma": "comprimé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Non commercialisée",
      "date_amm": "31/05/2012",
      "statut_bdm": "Warning disponibilité",
      "num_autorisation_euro": "",
      "titulaire": "GENEVIDA (ALLEMAGNE)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "64127672",
      "denomination": "ACARBOSE BIOGARAN 100 mg, comprimé sécable",
      "forme_pharma": "comprimé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "04/11/2009",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BIOGARAN",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "69116854",
      "denomination": "ACARBOSE BIOGARAN 50 mg, comprimé",
      "forme_pharma": "comprimé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "04/11/2009",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BIOGARAN",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "65803331",
      "denomination": "ACARBOSE EG 100 mg, comprimé",
      "forme_pharma": "comprimé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "01/03/2013",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "EG LABO - LABORATOIRES EUROGENERICS",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "61937888",
      "denomination": "ACARBOSE EG 50 mg, comprimé",
      "forme_pharma": "comprimé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "01/03/2013",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "EG LABO - LABORATOIRES EUROGENERICS",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "67093136",
      "denomination": "ACARBOSE SANDOZ 100 mg, comprimé",
      "forme_pharma": "comprimé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "11/04/2013",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "SANDOZ",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "69771614",
      "denomination": "ACARBOSE SANDOZ 50 mg, comprimé",
      "forme_pharma": "comprimé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "11/04/2013",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "SANDOZ",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "60946941",
      "denomination": "ACARBOSE VIATRIS 100 mg, comprimé sécable",
      "forme_pharma": "comprimé sécable",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "16/10/2013",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "VIATRIS SANTE",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "60989978",
      "denomination": "ACARBOSE VIATRIS 50 mg, comprimé",
      "forme_pharma": "comprimé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "16/10/2013",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "VIATRIS SANTE",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "67901945",
      "denomination": "ACARBOSE ZENTIVA 100 mg, comprimé sécable",
      "forme_pharma": "comprimé sécable",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "08/12/2009",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "ZENTIVA FRANCE",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "64493666",
      "denomination": "ACARBOSE ZENTIVA 50 mg, comprimé",
      "forme_pharma": "comprimé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "08/12/2009",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "ZENTIVA FRANCE",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "67813445",
      "denomination": "ACARIZAX 12 SQ-HDM, lyophilisat sublingual",
      "forme_pharma": "lyophilisat",
      "voies_admin": "sublinguale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure décentralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "15/01/2016",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "ALK ABELLO (DANEMARK)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "61823354",
      "denomination": "ACCOFIL 12 MU/0,2 ml, solution injectable ou pour perfusion en seringue préremplie",
      "forme_pharma": "solution injectable ou pour perfusion",
      "voies_admin": "intraveineuse;sous-cutanée",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "24/06/2022",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/14/946",
      "titulaire": "ACCORD HEALTHCARE (ESPAGNE)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "68056062",
      "denomination": "ACCOFIL 30 MU/0,5 ml, solution injectable ou pour perfusion en seringue préremplie",
      "forme_pharma": "solution injectable ou pour perfusion",
      "voies_admin": "intraveineuse;sous-cutanée",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "18/09/2014",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/14/946",
      "titulaire": "ACCORD HEALTHCARE (ESPAGNE)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "60812344",
      "denomination": "ACCOFIL 48 MU/0,5 ml, solution injectable ou pour perfusion en seringue préremplie",
      "forme_pharma": "solution injectable ou pour perfusion",
      "voies_admin": "intraveineuse;sous-cutanée",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "18/09/2014",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/14/946",
      "titulaire": "ACCORD HEALTHCARE (ESPAGNE)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "63909873",
      "denomination": "ACCOFIL 70 MU/0,73 ml, solution injectable ou pour perfusion en seringue préremplie",
      "forme_pharma": "solution injectable ou pour perfusion",
      "voies_admin": "intraveineuse;sous-cutanée",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure centralisée",
      "commercialisation": "Commercialisée",
      "date_amm": "24/06/2022",
      "statut_bdm": "",
      "num_autorisation_euro": "EU/1/14/946",
      "titulaire": "ACCORD HEALTHCARE (ESPAGNE)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "67627711",
      "denomination": "ACCUSOL 35 POTASSIUM 2 mmol/l, solution pour hémofiltration, hémodialyse et hémodiafiltration",
      "forme_pharma": "solution et  solution pour hémofiltration pour hémodialyse et pour hémodiafiltration",
      "voies_admin": "hémodialyse;hémofiltration;voie extracorporelle autre",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure de reconnaissance mutuelle",
      "commercialisation": "Commercialisée",
      "date_amm": "15/05/2006",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "NIKKISO BELGIUM (BELGIQUE)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "61278936",
      "denomination": "ACCUSOL 35 POTASSIUM 4 mmol/l, solution pour hémofiltration, hémodialyse et hémodiafiltration",
      "forme_pharma": "solution et  solution pour hémofiltration pour hémodialyse et pour hémodiafiltration",
      "voies_admin": "hémodialyse;hémofiltration",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure de reconnaissance mutuelle",
      "commercialisation": "Commercialisée",
      "date_amm": "15/05/2006",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "NIKKISO BELGIUM (BELGIQUE)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "69430342",
      "denomination": "ACCUSOL 35, solution pour hémofiltration, hémodialyse et hémodiafiltration",
      "forme_pharma": "solution et  solution pour hémofiltration pour hémodialyse et pour hémodiafiltration",
      "voies_admin": "hémodialyse;hémofiltration",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure de reconnaissance mutuelle",
      "commercialisation": "Commercialisée",
      "date_amm": "15/05/2006",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "NIKKISO BELGIUM (BELGIQUE)",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "63880820",
      "denomination": "ACEBUTOLOL ALMUS 200 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "12/06/2008",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BIOGARAN",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "66904792",
      "denomination": "ACEBUTOLOL ARROW 200 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation abrogée",
      "type_amm": "Procédure nationale",
      "commercialisation": "Non commercialisée",
      "date_amm": "28/05/2002",
      "statut_bdm": "Warning disponibilité",
      "num_autorisation_euro": "",
      "titulaire": "ARROW GENERIQUES",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "62096139",
      "denomination": "ACEBUTOLOL ARROW 400 mg, comprimé pelliculé sécable",
      "forme_pharma": "comprimé pelliculé sécable",
      "voies_admin": "orale",
      "statut_amm": "Autorisation abrogée",
      "type_amm": "Procédure nationale",
      "commercialisation": "Non commercialisée",
      "date_amm": "28/05/2002",
      "statut_bdm": "Warning disponibilité",
      "num_autorisation_euro": "",
      "titulaire": "ARROW GENERIQUES",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "63661520",
      "denomination": "ACEBUTOLOL ARROW LAB 200 mg, comprimé pelliculé sécable",
      "forme_pharma": "comprimé pelliculé sécable",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "28/05/2019",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "ARROW GENERIQUES",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "68167148",
      "denomination": "ACEBUTOLOL ARROW LAB 400 mg, comprimé pelliculé sécable",
      "forme_pharma": "comprimé pelliculé sécable",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "28/05/2019",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "ARROW GENERIQUES",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "65637614",
      "denomination": "ACEBUTOLOL BIOGARAN 200 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "30/11/1999",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BIOGARAN",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "60281598",
      "denomination": "ACEBUTOLOL BIOGARAN 400 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "30/11/1999",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "BIOGARAN",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "64021217",
      "denomination": "ACEBUTOLOL CRISTERS 200 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "28/05/2002",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "CRISTERS",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "69461099",
      "denomination": "ACEBUTOLOL EG 200 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "21/06/2000",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "EG LABO - LABORATOIRES EUROGENERICS",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "63874155",
      "denomination": "ACEBUTOLOL EG 400 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "21/06/2000",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "EG LABO - LABORATOIRES EUROGENERICS",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "64304820",
      "denomination": "ACEBUTOLOL SANDOZ 200 mg, comprimé enrobé",
      "forme_pharma": "comprimé enrobé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "10/05/1999",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "SANDOZ",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "67050875",
      "denomination": "ACEBUTOLOL SANDOZ 400 mg, comprimé enrobé",
      "forme_pharma": "comprimé enrobé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "26/04/1999",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "SANDOZ",
      "surveillance_renforcee": "Non"
    },
    {
      "cis": "64847741",
      "denomination": "ACEBUTOLOL TEVA 200 mg, comprimé pelliculé",
      "forme_pharma": "comprimé pelliculé",
      "voies_admin": "orale",
      "statut_amm": "Autorisation active",
      "type_amm": "Procédure nationale",
      "commercialisation": "Commercialisée",
      "date_amm": "26/04/1995",
      "statut_bdm": "",
      "num_autorisation_euro": "",
      "titulaire": "TEVA SANTE",
      "surveillance_renforcee": "Non"
    }
  ],
  "pagination": {
    "total": 15788,
    "page": 1,
    "limit": 100,
    "pages": 158
  },
  "metadata": {
    "last_updated": "2026-03-17T08:16:29.478Z",
    "source": "base de données publique des médicaments - gouv.fr"
  }
}